CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

But in mid-May, the Food and Drug Administration (FDA) approved the non-hormonal drug Fezolinetant, under the brand name Veozah, for the treatment of hot flashes and night sweats. The drug was ...

Those hot flashes, called vasomotor symptoms ... If you’re looking for a non-hormonal treatment, speak with your doctor to see if Veozah is right for you. Moreno advises women to undergo health ...

While not quite as effective as the standard treatment ... hormonal therapy, such as breast cancer survivors. The pills will be marketed as Veozah to treat moderate to severe hot flashes ...

The drug, deemed elinzanetant, can help reduced hot flashes and improve sleep for ... milestone in our efforts to offer a new non-hormonal option for women. This further underscores our position ...

Available treatments may not stop hot flashes entirely ... fully disclose their family and medical history. There are also non-hormone drugs that have been found effective in treating hot flashes.

Women who can’t or choose not to take hormones to ease hot flashes, a common symptom in menopause, have always been forced to consider other treatments ... not to take hormone therapy ...

Smoking, pregnancy, and having an over- or under-active thyroid may trigger a hot flash. Read on to learn about more causes, as well as treatments ... including hormonal changes, stress and ...

The menopause treatment fezolinetant has been predicted as a “gamechanger” by experts for thousands of women who suffer from hot flushes. The drug, which is the first non-hormonal menopause ...